Moffitt Cancer Center Partners with AbbVie to Advance New Cancer Treatments
TAMPA, Fla. — Moffitt Cancer Center announced a five-year strategic alliance with AbbVie Inc. aims to accelerate the development of new cancer therapies and expand patient treatment options. The collaboration combines AbbVie’s oncology research capabilities with Moffitt’s clinical expertise to advance care in areas where treatment options remain limited.
Building on a long-standing partnership in preclinical and clinical research, the alliance is set to support the development of therapeutic agents through early stage programs, translational and clinical research, and real-world evidence data generation. Through this partnership, AbbVie will engage with the Moffitt team and have priority access to its clinical environment to accelerate oncology innovation and help create pathways that support the development of new therapeutic approaches.
“This alliance reflects our commitment to bringing innovative therapies to cancer patients more quickly,” said Karen Lu, M.D., physician in chief at Moffitt. “Combining AbbVie’s drug development expertise with our clinical capabilities will accelerate discovery and testing of new treatments. This partnership expands access to options for patients facing urgent needs. Our goal is to improve outcomes through focused research and efficient clinical trials that translate science into care without delay.”
“We are deeply energized by our strategic alliance with Moffitt Cancer Center, which brings together world-class scientific innovation and clinical expertise in oncology,” said Svetlana Kobina, M.D., Ph.D., vice president of AbbVie Oncology, Global Medical Affairs. “Leveraging Moffitt’s strengths in translational and clinical research, this collaboration is designed to move discoveries rapidly from bench to bedside. Our shared commitment is to accelerate the development of new therapies, expand patient access to promising treatment options and make a meaningful difference in the lives of those impacted by cancer.”
About Moffitt Cancer Center
Moffitt is dedicated to one lifesaving mission: to contribute to the prevention and cure of cancer. The Tampa-based facility is one of only 57 National Cancer Institute-designated Comprehensive Cancer Centers, a distinction that recognizes Moffitt’s scientific excellence, multidisciplinary research, and robust training and education. Moffitt’s expert nursing staff is recognized by the American Nurses Credentialing Center with Magnet® status, its highest distinction. For more information, call 1-888-MOFFITT (1-888-663-3488), visit MOFFITT.org, and follow the momentum on Facebook, X, Instagram and YouTube.
###
